Cattle Abortions and Congenital Malformations Due to Bluetongue Virus Serotype 3 in Southern Belgium, 2024
Viruses · 2025
DOI: 10.3390/v17101356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Laurent Delooz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regional Association for Animal Registration and Health (ARSIA) asbl, 5590 Ciney, Belgium. Hauptthemen laut MEDLINE: Bluetongue virus, Bluetongue, Abortion, Veterinary, Cattle Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Belgian Federal Agency for the Safety of the Food Chain.
Abstract (Originalsprache)
In July 2024, bluetongue virus serotype 3 (BTV-3) was first detected in southern Belgium, marking the onset of a major epidemic wave. This study documents, for the first time in Belgium, the ability of BTV-3 to cross the placental barrier in cattle, causing abortions and congenital central nervous system malformations. Abortion cases from January to December 2024 were monitored through the national abortion protocol, which mandates reporting and laboratory investigation (i.e., the year of emergence and the three previous years as the baseline data set). Among 5,751 reported abortions, 903 foetuses were tested by PCR, revealing widespread BTV-3 circulation. The first malformed PCR-positive foetus was recorded in mid-August, four weeks after a sharp increase in abortion rates. Lesions such as hydranencephaly were confirmed in PCR-positive foetuses, with a malformation rate of 32.24% in affected herds from weeks 36 to 52 (i.e., 22 times higher than in previous years). Gestational stage analysis indicated that congenital lesions were most frequent following infection between 70 and 130 days of gestation. Based on the observed gross lesions and the timing of abortion, it was deduced that the earliest maternal infections likely occurred in February–March 2024, implying low-level winter BTV-3 circulation before the official detection of the epidemic wave. These findings highlight the epidemiological value of systematic abortion monitoring as an early warning system tool and highlight the inadequacy of relying solely on clinical surveillance in adult ruminants. The abrupt emergence of BTV-3 across the territory without a gradual spatial spread underscores the need for anticipatory control strategies. Strategic, multivalent vaccination campaigns and enhanced abortion surveillance are critical to mitigate similar reproductive and economic losses in future bluetongue outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regional Association for Animal Registration and Health (ARSIA) asbl, 5590 Ciney, Belgium.
- Research Unit of Epidemiology and Risk Analysis Applied to Veterinary Science (UREAR-ULiège), Fundamental and Applied Research for Animals & Health (FARAH) Center, Faculty of Veterinary Medicine, University of Liege, 40…
- Service of Exotic and Vector-Borne Diseases, National Reference Laboratory for Bluetongue, Sciensano, 1080 Brussels, Belgium.
ORCID-Profile: Laurent Delooz, Ilse De Leeuw, Claude Saegerman
Förderung
- Belgian Federal Agency for the Safety of the Food Chain
Zitieren
APA
Delooz, L., De Regge, N., De Leeuw, I., Smeets, F., Petitjean, T., Grégoire, F., & Saegerman, C. (2025). Cattle Abortions and Congenital Malformations Due to Bluetongue Virus Serotype 3 in Southern Belgium, 2024. Viruses. https://doi.org/10.3390/v17101356
Vancouver
Delooz L, De Regge N, De Leeuw I, Smeets F, Petitjean T, Grégoire F, et al. Cattle Abortions and Congenital Malformations Due to Bluetongue Virus Serotype 3 in Southern Belgium, 2024. Viruses. 2025. doi:10.3390/v17101356
BibTeX
@article{Delooz2025,
author = {Delooz, Laurent and De Regge, Nick and De Leeuw, Ilse and Smeets, Frédéric and Petitjean, Thierry and Grégoire, Fabien and Saegerman, Claude},
title = {Cattle Abortions and Congenital Malformations Due to Bluetongue Virus Serotype 3 in Southern Belgium, 2024},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17101356}
}
EUVIMED